Literature DB >> 17949857

Prominent phenotypic variability associated with mutations in Progranulin.

Brendan J Kelley1, Wael Haidar, Bradley F Boeve, Matt Baker, Neill R Graff-Radford, Thomas Krefft, Andrew R Frank, Clifford R Jack, Maria Shiung, David S Knopman, Keith A Josephs, Sotirios A Parashos, Rosa Rademakers, Mike Hutton, Stuart Pickering-Brown, Jennifer Adamson, Karen M Kuntz, Dennis W Dickson, Joseph E Parisi, Glenn E Smith, Robert J Ivnik, Ronald C Petersen.   

Abstract

Mutations in progranulin (PGRN) are associated with frontotemporal dementia with or without parkinsonism. We describe the prominent phenotypic variability within and among eight kindreds evaluated at Mayo Clinic Rochester and/or Mayo Clinic Jacksonville in whom mutations in PGRN were found. All available clinical, genetic, neuroimaging and neuropathologic data was reviewed. Age of onset ranged from 49 to 88 years and disease duration ranged from 1 to 14 years. Clinical diagnoses included frontotemporal dementia (FTD), primary progressive aphasia, FTD with parkinsonism, parkinsonism, corticobasal syndrome, Alzheimer's disease, amnestic mild cognitive impairment, and others. One kindred exhibited maximal right cerebral hemispheric atrophy in all four affected individuals, while another had maximal left hemisphere involvement in all three of the affected. Neuropathologic examination of 13 subjects revealed frontotemporal lobar degeneration with ubiquitin-positive inclusions plus neuronal intranuclear inclusions in all cases. Age of onset, clinical phenotypes and MRI findings associated with most PGRN mutations varied significantly both within and among kindreds. Some kindreds with PGRN mutations exhibited lateralized topography of degeneration across all affected individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17949857      PMCID: PMC3164546          DOI: 10.1016/j.neurobiolaging.2007.08.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  53 in total

1.  Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22.

Authors:  S M Rosso; W Kamphorst; B de Graaf; R Willemsen; R Ravid; M F Niermeijer; M G Spillantini; P Heutink; J C van Swieten
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

2.  Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21-22.

Authors:  Armand Savioz; Beat M Riederer; Peter Heutink; Patrizia Rizzu; Markus Tolnay; Enikö Kövari; Alphonse Probst; I rène M Riederer; Constantin Bouras; Geneviève Leuba
Journal:  Neurobiol Dis       Date:  2003-02       Impact factor: 5.996

Review 3.  Tau gene mutations: dissecting the pathogenesis of FTDP-17.

Authors:  Esther M Ingram; Maria G Spillantini
Journal:  Trends Mol Med       Date:  2002-12       Impact factor: 11.951

4.  Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval.

Authors:  R Rademakers; M Cruts; B Dermaut; K Sleegers; S M Rosso; M Van den Broeck; H Backhovens; J van Swieten; C M van Duijn; C Van Broeckhoven
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  Frontotemporal dementia linked to chromosome 3.

Authors:  Jerry Brown; Susanne Gydesen; Peter Johannsen; Anders Gade; Gaia Skibinski; Lisa Chakrabarti; Arne Brun; Maria Spillantini; Despina Yancopoulou; Tove Thusgaard; Asger Sorensen; Elizabeth Fisher; John Collinge
Journal:  Dement Geriatr Cogn Disord       Date:  2004       Impact factor: 2.959

6.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry.

Authors:  K A Josephs; J L Holton; M N Rossor; A K Godbolt; T Ozawa; K Strand; N Khan; S Al-Sarraj; T Revesz
Journal:  Neuropathol Appl Neurobiol       Date:  2004-08       Impact factor: 8.090

7.  Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology.

Authors:  B F Boeve; D M Maraganore; J E Parisi; R J Ivnik; B F Westmoreland; D W Dickson; M Hutton; J Hardy; R J Caselli; R C Petersen
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 8.  Granulin precursor gene: a sex steroid-inducible gene involved in sexual differentiation of the rat brain.

Authors:  Masatoshi Suzuki; Masugi Nishiahara
Journal:  Mol Genet Metab       Date:  2002-01       Impact factor: 4.797

9.  Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions.

Authors:  A Kertesz; T Kawarai; E Rogaeva; P St George-Hyslop; P Poorkaj; T D Bird; D G Munoz
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

Review 10.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia.

Authors:  Bradley F Boeve; Anthony E Lang; Irene Litvan
Journal:  Ann Neurol       Date:  2003       Impact factor: 10.422

View more
  79 in total

1.  Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population.

Authors:  Zhihong Shi; Shuai Liu; Lei Xiang; Ying Wang; Mengyuan Liu; Shuling Liu; Tong Han; Yuying Zhou; Jinhuan Wang; Li Cai; Shuo Gao; Yong Ji
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

2.  Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN.

Authors:  J L Whitwell; S D Weigand; J L Gunter; B F Boeve; R Rademakers; M Baker; D S Knopman; Z K Wszolek; R C Petersen; C R Jack; K A Josephs
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Imaging correlates of pathology in corticobasal syndrome.

Authors:  J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

4.  Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN.

Authors:  J L Whitwell; C R Jack; B F Boeve; M L Senjem; M Baker; R Rademakers; R J Ivnik; D S Knopman; Z K Wszolek; R C Petersen; K A Josephs
Journal:  Neurology       Date:  2009-03-03       Impact factor: 9.910

5.  Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.

Authors:  Corey T McMillan; Jon B Toledo; Brian B Avants; Philip A Cook; Elisabeth M Wood; Eunran Suh; David J Irwin; John Powers; Christopher Olm; Lauren Elman; Leo McCluskey; Gerard D Schellenberg; Virginia M-Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman
Journal:  Neurobiol Aging       Date:  2013-12-02       Impact factor: 4.673

6.  Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation.

Authors:  G Gliebus; E H Bigio; K Gasho; M Mishra; D Caplan; M-M Mesulam; C Geula
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

7.  rs5848 polymorphism and serum progranulin level.

Authors:  Ging-Yuek R Hsiung; Alice Fok; Howard H Feldman; Rosa Rademakers; Ian R A Mackenzie
Journal:  J Neurol Sci       Date:  2010-11-02       Impact factor: 3.181

8.  C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.

Authors:  Aleksandra Wojtas; Kristin A Heggeli; Nicole Finch; Matt Baker; Mariely Dejesus-Hernandez; Steven G Younkin; Dennis W Dickson; Neill R Graff-Radford; Rosa Rademakers
Journal:  Am J Neurodegener Dis       Date:  2012-05-16

Review 9.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 10.  Neurodegenerative dementia and parkinsonism.

Authors:  A Gabelle; F Portet; C Berr; J Touchon
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.